309 related articles for article (PubMed ID: 27959428)
1. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
[TBL] [Abstract][Full Text] [Related]
2. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
[TBL] [Abstract][Full Text] [Related]
3. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
[TBL] [Abstract][Full Text] [Related]
4. Aberrant DKK3 expression in the oral leukoplakia and oral submucous fibrosis: a comparative immunohistochemical study.
Al-Dhohorah T; Mashrah M; Yao Z; Huang J
Eur J Histochem; 2016 Jun; 60(2):2629. PubMed ID: 27349317
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
7. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
[TBL] [Abstract][Full Text] [Related]
8. Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis.
Bag S; Dutta D; Chaudhary A; Sing BC; Pal M; Ray AK; Banerjee R; Paul RR; Basak A; Das AK; Chatterjee J
J Clin Pathol; 2018 Mar; 71(3):228-238. PubMed ID: 28821582
[TBL] [Abstract][Full Text] [Related]
9. IRF4 as a novel target involved in malignant transformation of oral submucous fibrosis into oral squamous cell carcinoma.
Meng L; Jiang Y; You J; Zhao P; Liu W; Zhao N; Yu Z; Ma J
Sci Rep; 2023 Feb; 13(1):2775. PubMed ID: 36797470
[TBL] [Abstract][Full Text] [Related]
10. The E3 ubiquitin ligase SIAH2 is a prosurvival factor overexpressed in oral cancer.
Hsieh SC; Kuo SN; Zheng YH; Tsai MH; Lin YS; Lin JH
Anticancer Res; 2013 Nov; 33(11):4965-73. PubMed ID: 24222137
[TBL] [Abstract][Full Text] [Related]
11. Survivin as a potential early marker in the carcinogenesis of oral submucous fibrosis.
Zhou S; Qu X; Yu Z; Zhong L; Ruan M; Ma C; Wang M; Zhang C; Jian X
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):575-81. PubMed ID: 20303055
[TBL] [Abstract][Full Text] [Related]
12. [Molecules of G(2)/M phase and the phosphorylation of survivin in the carcinogenesis of oral submucosal fibrosis].
Zhou SH; Li LL; Jian XC; Wang Y; Chen XQ; Gao X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Dec; 43(12):709-12. PubMed ID: 19134343
[TBL] [Abstract][Full Text] [Related]
13. Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma.
Hu X; Xiong H; Wang W; Huang L; Mao T; Yang L; Wang C; Huang D; Wu J; Xia K; Su T
Arch Oral Biol; 2020 Apr; 112():104687. PubMed ID: 32114253
[TBL] [Abstract][Full Text] [Related]
14. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
[TBL] [Abstract][Full Text] [Related]
15. Connecting cyto-nano-architectural attributes and epithelial molecular expression in oral submucous fibrosis progression to cancer.
Bag S; Pal M; Chaudhary A; Das RK; Paul RR; Sengupta S; Chatterjee J
J Clin Pathol; 2015 Aug; 68(8):605-13. PubMed ID: 26038241
[TBL] [Abstract][Full Text] [Related]
16. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway.
Zhou S; Zhu Y; Li Z; Zhu Y; He Z; Zhang C
J Cell Mol Med; 2021 Feb; 25(4):2262-2273. PubMed ID: 33345447
[TBL] [Abstract][Full Text] [Related]
17. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Eskander RN; Ali S; Dellinger T; Lankes HA; Randall LM; Ramirez NC; Monk BJ; Walker JL; Eisenhauer E; Hoang BH
Int J Gynecol Cancer; 2016 Jan; 26(1):125-32. PubMed ID: 26397159
[TBL] [Abstract][Full Text] [Related]
18. [A retrospective study of oral squamous cell carcinomas originated from oral submucous fibrosis].
Guo F; Jian XC; Zhou SH; Li N; Hu YJ; Tang ZG
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Aug; 46(8):494-7. PubMed ID: 22169748
[TBL] [Abstract][Full Text] [Related]
19. p16 as an independent marker for detection of high-risk HPV in oral submucous fibrosis and oral squamous cell carcinoma.
Sudhakaran A; Hallikeri K; Babu B
Indian J Pathol Microbiol; 2019; 62(4):523-528. PubMed ID: 31611434
[TBL] [Abstract][Full Text] [Related]
20. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP.
Trivedy C; Warnakulasuriya KA; Tavassoli M; Steingrimsdottir H; Penhallow J; Maher R; Johnson NW
J Oral Pathol Med; 1998 Feb; 27(2):72-7. PubMed ID: 9526733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
